IL1B and breast cancer: Since IL-1β contributed to a significant decrease in ERα levels [76], further studies should be conducted to unravel the hidden reasons for such BC subtype conversion after nCT and clarify whether inflammasome pathway and the subsequent IL-1β secretion are responsible for such change.